Literature DB >> 18976884

High prevalence of epilepsy in a village in the Littoral Province of Cameroon.

Francesca Prischich1, Marta De Rinaldis, Flaminia Bruno, Gabriella Egeo, Chiara Santori, Alessandra Zappaterreno, Jinane Fattouch, Carlo Di Bonaventura, Jean Bada, Gianluca Russo, Antonio Pizzuti, Francesco Cardona, Vincenzo Vullo, Anna Teresa Giallonardo, Emilio D'Erasmo, Andrea Pelliccia, Nicola Vanacore.   

Abstract

PURPOSE: In the Littoral Province of Cameroon, in the Sanaga River Valley, a door-to-door epidemiological study was carried out in order to evaluate the prevalence of epilepsy in a small village located in a geographically isolated area, hyper-endemic for onchocerciasis. It was followed by an electro-clinical evaluation of patients and a case-control study.
METHODS: The study involved a three-phases design: in phase I, a screening questionnaire was administered, in phase II, the presence of epilepsy was confirmed with electro-clinical evaluation, and in phase III, risk factors for epilepsy, socio-economical factors and life habits were evaluated in patients and two matched controls for the age (+/-1 year) residents in the same village. Endemicity level of onchocerciasis was assessed in the village by measuring the prevalence of nodules in adult males aged >or=20 years (PNAM).
RESULTS: One hundred eighty-one subjects (100 male and 81 female) were examined (91.9% of the overall population). The crude prevalence rate of active epilepsy was 105 per 1000 pop (CI 95% 60-150) while the age-adjusted prevalence rate was 134.5 cases per 1000 pop (CI 95% 90-178). Seizures were classified as generalized in 10 patients (52.6%) and partial in nine (47.4%). In 17 patients EEG was recorded. Afterward the electro-clinical classification this distribution was inverted: generalized seizures occurred in 35.3% of cases and partial seizures in 64.7% of cases. The PNAM was 62.5%. The surveyed village was classified as hyper-endemic for onchocerciasis. Among risk factors, only positive family history for epilepsy was found (p=0.031). A sample pedigree of a family with 10 epileptic cases (4 included in the epidemiological study) was showed.
CONCLUSIONS: To our knowledge, this is the first door-to-door study that produce an adjusted prevalence rate on epilepsy in Cameroon. In according to studies done in Tanzania, Liberia, Uganda, and Ethiopia, our results (i.e., the high prevalence rate in a restricted area, the clinical characteristics of epileptic seizures, the positive family history for epilepsy and the type of pedigree of a family with epileptic patients) may be accounted for by the presence of an strong interaction between environmental and genetic factors in some circumscribed areas.

Entities:  

Mesh:

Year:  2008        PMID: 18976884     DOI: 10.1016/j.eplepsyres.2008.09.004

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  24 in total

1.  Nodding syndrome, western Uganda, 1994.

Authors:  Christoph Kaiser; Tom Rubaale; Ephraim Tukesiga; Walter Kipp; George Asaba
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

Review 2.  Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa.

Authors:  Awa Ba-Diop; Benoît Marin; Michel Druet-Cabanac; Edgard B Ngoungou; Charles R Newton; Pierre-Marie Preux
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

Review 3.  Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies.

Authors:  Kirsten M Fiest; Khara M Sauro; Samuel Wiebe; Scott B Patten; Churl-Su Kwon; Jonathan Dykeman; Tamara Pringsheim; Diane L Lorenzetti; Nathalie Jetté
Journal:  Neurology       Date:  2016-12-16       Impact factor: 9.910

4.  River blindness goes beyond the eye: autoimmune antibodies, cross-reactive with Onchocerca volvulus antigen, detected in brain of patients with Nodding syndrome.

Authors:  Christoph Kaiser; Sébastien D S Pion
Journal:  Ann Transl Med       Date:  2017-12

5.  Epilepsy in Tanzanian children: association with perinatal events and other risk factors.

Authors:  Kathryn J Burton; Jane Rogathe; Roger Whittaker; Kshitij Mankad; Ewan Hunter; Matthew J Burton; Jim Todd; Brian G R Neville; Richard Walker; Charles R J C Newton
Journal:  Epilepsia       Date:  2012-02-06       Impact factor: 5.864

Review 6.  Case-control studies on the relationship between onchocerciasis and epilepsy: systematic review and meta-analysis.

Authors:  Christoph Kaiser; Sébastien D S Pion; Michel Boussinesq
Journal:  PLoS Negl Trop Dis       Date:  2013-03-28

7.  Prevalence and risk factors for Active Convulsive Epilepsy in Kintampo, Ghana.

Authors:  Kenneth Ayuurebobi Ae-Ngibise; Bright Akpalu; Anthony Ngugi; Albert Akpalu; Francis Agbokey; Patrick Adjei; Damien Punguyire; Christian Bottomley; Charles Newton; Seth Owusu-Agyei
Journal:  Pan Afr Med J       Date:  2015-05-13

8.  Addressing the treatment gap and societal impact of epilepsy in Rwanda--Results of a survey conducted in 2005 and subsequent actions.

Authors:  Fidèle Sebera; Naasson Munyandamutsa; Dirk E Teuwen; Ibrahim Pierre Ndiaye; Amadou Gallo Diop; Azita Tofighy; Paul Boon; Peter Dedeken
Journal:  Epilepsy Behav       Date:  2015-04-30       Impact factor: 2.937

9.  Epilepsy prevalence in the 0-17 age group in trabzon, Turkey.

Authors:  Murat Topbaş; Sükrü Ozgün; Müjgan F Sönmez; Ayşe Aksoy; Gamze Can; Asuman Yavuzyilmaz; Emine Can
Journal:  Iran J Pediatr       Date:  2012-09       Impact factor: 0.364

10.  An estimate of the prevalence of epilepsy in Sub-Saharan Africa: A systematic analysis.

Authors:  Abigail Paul; Davies Adeloye; Rhiannon George-Carey; Ivana Kolčić; Liz Grant; Kit Yee Chan
Journal:  J Glob Health       Date:  2012-12       Impact factor: 4.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.